michigan semaglutide gastroparesis legal team A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company What Should I Do If

Front Pharmacol 16:1529652 Model JFA, Normann RS, Vogt vertonL et al (2024) Interactions between glucagon like peptide 1 (GLP-1) and estrogens regulates lipid metabolism

Deaths in semaglutide FAERS reports since 2020 (USA TODAY/Gannett analysis) Pending cases in GLP-1 MDL-3094 up 153% in 14 months (MDL Update) Americans currently using a GLP-1 drug (KFF Health Tracking Poll) What the FDA Found The warning letter details five specific cases where Novo Nordisk's internal procedures prevented adverse events from reaching the FDA

McGraw-Hill / Lange rxlist.com (Tragenta ) Alogliptin Trade Name: Nesina Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: does not undergo significant metabolism, and is mostly excreted unchanged in the urine (76%) and feces (13%) dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)

This review found no evidence of a causal link between semaglutide and NAION